Bulletin
Investor Alert

London Markets Open in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 18, 2022, 4:47 p.m.

/zigman2/quotes/206690250/composite

$

88.42

Change

0.00 0.00%

Volume

Volume 84,542

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 92.90

$ 88.42

Change

-4.48 -4.82%

Day low

Day high

$87.74

$92.13

Open

52 week low

52 week high

$82.51

$120.54

Open

Jeff Himawan

Founder of Seed-One Ventures LLC and Elusys Therapeutics, Inc., Jeff Himawan is Chairman of MediciNova, Inc. and Managing Director at Essex Woodlands Management, Inc., Managing Director at Essex Woodlands Health Ventures LP (a subsidiary of Essex Woodlands Management, Inc.). He is also on the board of Horizon Therapeutics Plc, Horizon Therapeutics USA, Inc., NexEos Diagnostics, Inc. and NexEos Bio, Inc. and Managing Director at Essex Woodlands Health Ventures LP.

Dr. Himawan previously held the position of Director at Light Sciences Oncology, Inc., Managing Director at Seed-One Ventures LLC and Principal at Genzyme Corp.

Jeff Himawan received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard University.

Transactions

Date Shares Transaction Value
04/29/2022 1,139   Derivative/Non-derivative trans. at $98.56 per share. 112,260
04/29/2022 4,223   Derivative/Non-derivative trans. at $0 per share. 0
04/30/2021 11,098   Derivative/Non-derivative trans. at $0 per share. 0
05/02/2020 4,151   Derivative/Non-derivative trans. at $35.62 per share. 147,859
05/02/2020 15,390   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2019 4,132   Derivative/Non-derivative trans. at $26.54 per share. 109,664
05/03/2019 15,320   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2018 3,790   Derivative/Non-derivative trans. at $13.87 per share. 52,568
05/03/2018 14,054   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.